Dr. Reddy's Laboratories Limited

NSE: DRREDDY

Compare with…

Employs 28,091 permanent employees and workers, 2.1% on the year before, as filed for the year to 31 Mar 2026 on a group basis. Revenue in the quarter to 30 Jun 2026 was ₹5,137 cr.

Headcount

Annual, from the BRSR filed with NSE (as of 31 March each year)

Permanent
Contract / other
As ofScopePermanentChange (%)Contract / otherChange (%)
31 Mar 2022Standalone20,651—10,118—
31 Mar 2023Group⚠25,4984,847(23.5%)13,1012,983(29.5%)
31 Mar 2024Group26,9861,488(5.8%)16,8833,782(28.9%)
31 Mar 2025Group27,517531(2.0%)16,035−848(5.0%)
31 Mar 2026Group28,091574(2.1%)14,396−1,639(10.2%)
  • ⚠The reporting scope changed from the previous period, so the two are not comparable.

Permanent = permanent employees + permanent workers, as defined in SEBI's BRSR. "Standalone" figures cover the listed company alone and exclude its subsidiaries.

Financials (₹ cr)

Revenue (₹ cr)
Employee cost (₹ cr)
Net profit (₹ cr)
PeriodRevenue (₹ cr)Change (%)Employee cost (₹ cr)Change (%)Net profit (₹ cr)Change (%)Flags
Quarter ended 30 Jun 20265,1371,315(34.4%)967133(15.9%)405624(284.5%)
Quarter ended 31 Mar 20263,822−461(10.8%)835−126(13.1%)-219−310(342.2%)
Quarter ended 31 Dec 20254,283−336(7.3%)96092(10.6%)91−297(76.6%)
Quarter ended 30 Sept 20254,619−3,191(40.9%)868−19(2.2%)387−2,574(86.9%)
Quarter ended 30 Jun 20257,8102,247(40.4%)88790(11.3%)2,9611,761(146.6%)
Quarter ended 31 Mar 20255,563548(10.9%)7973(0.3%)1,201351(41.4%)
Quarter ended 31 Dec 20245,015−1,681(25.1%)794−46(5.4%)849−1,033(54.9%)
Quarter ended 30 Sept 20246,696855(14.6%)840−16(1.8%)1,882465(32.8%)
Quarter ended 30 Jun 20245,841736(14.4%)85676(9.8%)1,417382(37.0%)
Quarter ended 31 Mar 20245,1051,002(24.4%)780−3(0.4%)1,035560(117.8%)
Quarter ended 31 Dec 20234,103−736(15.2%)782−1(0.2%)475−717(60.2%)
Quarter ended 30 Sept 20234,839−599(11.0%)78444(5.9%)1,193−447(27.3%)
Quarter ended 30 Jun 20235,437883(19.4%)740−25(3.3%)1,639967(143.8%)
Quarter ended 31 Mar 20234,554656(16.8%)76557(8.0%)672348(107.1%)
Quarter ended 31 Dec 20223,898−983(20.1%)708−2(0.2%)325−792(70.9%)⚠
Quarter ended 30 Sept 20224,8801,250(34.4%)71061(9.4%)1,116617(123.5%)
Quarter ended 30 Jun 20223,631−38(1.0%)64940(6.6%)50080(19.0%)
Quarter ended 31 Mar 20223,669189(5.4%)6095(0.8%)42079(23.0%)⚠
Quarter ended 31 Dec 20213,480−344(9.0%)604−31(4.9%)341−108(24.0%)⚠
Quarter ended 30 Sept 20213,823390(11.4%)63549(8.3%)44936(8.6%)⚠
Quarter ended 30 Jun 20213,43483(2.5%)58741(7.5%)413102(32.7%)⚠
Quarter ended 31 Mar 20213,351−58(1.7%)546−26(4.5%)312−132(29.8%)⚠
Quarter ended 31 Dec 20203,40862(1.9%)572−37(6.0%)444−37(7.8%)⚠
Quarter ended 30 Sept 20203,346101(3.1%)60863(11.6%)481−469(49.4%)⚠
Quarter ended 30 Jun 20203,244393(13.8%)54528(5.5%)950447(89.0%)⚠
Quarter ended 31 Mar 20202,852−192(6.3%)5175(1.1%)503−19(3.6%)⚠
Quarter ended 31 Dec 20193,044−402(11.7%)5118(1.7%)522−843(61.8%)⚠
Quarter ended 30 Sept 20193,446937(37.4%)5033(0.6%)1,365817(149.1%)⚠
Quarter ended 30 Jun 20192,509−137(5.2%)50010(2.0%)548345(170.3%)⚠
Quarter ended 31 Mar 20192,645−87(3.2%)49018(3.8%)203−197(49.2%)⚠
Quarter ended 31 Dec 20182,732101(3.8%)472−31(6.2%)39953(15.4%)⚠
Quarter ended 30 Sept 20182,63113(0.5%)50336(7.7%)34617(5.3%)⚠
Quarter ended 30 Jun 20182,618125(5.0%)4674(0.8%)329152(86.1%)⚠
Quarter ended 31 Mar 20182,492—463—177—⚠
Period ended 31 Dec 202516,711—2,715—3,439—
Period ended 30 Sept 202512,4283,917(46.0%)1,755396(29.1%)3,3491,733(107.2%)
Period ended 30 Sept 20228,511—1,359—1,616—
Year ended 31 Mar 202620,533−2,583(11.2%)3,550262(8.0%)3,220−2,130(39.8%)
Year ended 31 Mar 202523,115—3,288—5,349—